Epigenetics in rhabdomyosarcoma: cues to new biomarkers and targeted therapies.
作者信息
Megiorni Francesca
机构信息
Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.
出版信息
EBioMedicine. 2020 Feb;52:102673. doi: 10.1016/j.ebiom.2020.102673. Epub 2020 Feb 12.
Abstract
摘要
相似文献
1
Epigenetics in rhabdomyosarcoma: cues to new biomarkers and targeted therapies.横纹肌肉瘤中的表观遗传学：新生物标志物及靶向治疗的线索
EBioMedicine. 2020 Feb;52:102673. doi: 10.1016/j.ebiom.2020.102673. Epub 2020 Feb 12.
2
Epigenetics of prostate cancer: distribution of histone H3K27me3 biomarkers in peri-tumoral tissue.前列腺癌的表观遗传学：组蛋白H3K27me3生物标志物在肿瘤周围组织中的分布
OMICS. 2014 Mar;18(3):207-9. doi: 10.1089/omi.2013.0117. Epub 2014 Feb 11.
3
Roles of enhancer of zeste homolog 2: from skeletal muscle differentiation to rhabdomyosarcoma carcinogenesis.zeste 同源物 2 增强子的作用：从骨骼肌分化到横纹肌肉瘤致癌作用
Cell Cycle. 2014;13(4):516-27. doi: 10.4161/cc.27921. Epub 2014 Jan 22.
4
Genetic biomarkers of hypertension and future challenges integrating epigenomics.高血压的遗传生物标志物和整合表观基因组学的未来挑战。
Clin Chim Acta. 2012 Dec 24;414:259-65. doi: 10.1016/j.cca.2012.09.018. Epub 2012 Sep 23.
5
Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma.全基因组DNA甲基化分析揭示了原钙黏蛋白α4在转移性和非转移性横纹肌肉瘤中的不同甲基化模式。
BMC Cancer. 2016 Nov 14;16(1):886. doi: 10.1186/s12885-016-2936-3.
6
The Development of Epigenetics in the Study of Disease Pathogenesis.表观遗传学在疾病发病机制研究中的发展。
Adv Exp Med Biol. 2020;1253:57-94. doi: 10.1007/978-981-15-3449-2_2.
7
Pharmacoepigenetics and Pharmacoepigenomics: An Overview.药物表观遗传学与药物表观基因组学：概述
Curr Drug Discov Technol. 2019;16(4):392-399. doi: 10.2174/1570163815666180419154633.
8
MicroRNAs and epigenetic mechanisms of rhabdomyosarcoma development.微小RNA与横纹肌肉瘤发生发展的表观遗传机制
Int J Biochem Cell Biol. 2014 Aug;53:482-92. doi: 10.1016/j.biocel.2014.05.003. Epub 2014 May 14.
9
Epigenetics make transient states of cancer therapy resistance permanent.表观遗传学使癌症治疗耐药的短暂状态永久化。
Sci Transl Med. 2017 Jun 28;9(396). doi: 10.1126/scitranslmed.aan6729.
10
The impact of epigenetics on cardiovascular disease.表观遗传学对心血管疾病的影响。
Biochem Cell Biol. 2020 Feb;98(1):12-22. doi: 10.1139/bcb-2019-0045. Epub 2019 May 21.
引用本文的文献
1
Pioneer in Molecular Biology: Conformational Ensembles in Molecular Recognition, Allostery, and Cell Function.分子生物学先驱：分子识别、别构效应及细胞功能中的构象集合体
J Mol Biol. 2025 Jun 1;437(11):169044. doi: 10.1016/j.jmb.2025.169044. Epub 2025 Feb 25.
2
Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States.分层医学儿科学：游离DNA和连续肿瘤测序可识别亚型特异性癌症演变及表观遗传状态。
Cancer Discov. 2025 Apr 2;15(4):717-732. doi: 10.1158/2159-8290.CD-24-0916.
3
DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells.DiPRO1 显著重编程肌肉和间充质癌细胞。
EMBO Mol Med. 2024 Aug;16(8):1840-1885. doi: 10.1038/s44321-024-00097-z. Epub 2024 Jul 15.
4
BRD4 isoforms have distinct roles in tumour progression and metastasis in rhabdomyosarcoma.BRD4 异构体在横纹肌肉瘤的肿瘤进展和转移中具有不同的作用。
EMBO Rep. 2024 Feb;25(2):832-852. doi: 10.1038/s44319-023-00033-1. Epub 2024 Jan 8.
5
A GRIP-1-EZH2 switch binding to GATA-4 is linked to the genesis of rhabdomyosarcoma through miR-29a.GATA-4 上的 GRIP1-EZH2 开关结合与 miR-29a 相关联，导致横纹肌肉瘤的发生。
Oncogene. 2022 Dec;41(49):5223-5237. doi: 10.1038/s41388-022-02521-5. Epub 2022 Oct 29.
6
Radioresistance in rhabdomyosarcomas: Much more than a question of dose.横纹肌肉瘤中的放射抗性：远不止剂量问题。
Front Oncol. 2022 Sep 29;12:1016894. doi: 10.3389/fonc.2022.1016894. eCollection 2022.
7
MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells.MS-275（恩替诺特）增强 PAX3-FOXO1 横纹肌肉瘤细胞的放射敏感性。
Int J Mol Sci. 2021 Oct 1;22(19):10671. doi: 10.3390/ijms221910671.
8
A bioengineering method for modeling alveolar Rhabdomyosarcoma and assessing chemotherapy responses.一种用于构建肺泡横纹肌肉瘤模型并评估化疗反应的生物工程方法。
MethodsX. 2021 Jul 27;8:101473. doi: 10.1016/j.mex.2021.101473. eCollection 2021.
本文引用的文献
1
Epigenetically upregulated GEFT-derived invasion and metastasis of rhabdomyosarcoma via epithelial mesenchymal transition promoted by the Rac1/Cdc42-PAK signalling pathway.通过 Rac1/Cdc42-PAK 信号通路促进上皮间质转化，表观遗传上调的 GEFT 导致横纹肌肉瘤的侵袭和转移。
EBioMedicine. 2019 Dec;50:122-134. doi: 10.1016/j.ebiom.2019.10.060. Epub 2019 Nov 21.
2
MiRNAs as Players in Rhabdomyosarcoma Development.miRNAs 在横纹肌肉瘤发生发展中的作用。
Int J Mol Sci. 2019 Nov 19;20(22):5818. doi: 10.3390/ijms20225818.
3
Genetics, epigenetics and redox homeostasis in rhabdomyosarcoma: Emerging targets and therapeutics.横纹肌肉瘤中的遗传学、表观遗传学和氧化还原稳态：新兴靶点和治疗方法。
Redox Biol. 2019 Jul;25:101124. doi: 10.1016/j.redox.2019.101124. Epub 2019 Jan 25.
4
Circ-ZNF609 regulates G1-S progression in rhabdomyosarcoma.环状锌指蛋白 609 调控横纹肌肉瘤的 G1-S 期进程。
Oncogene. 2019 May;38(20):3843-3854. doi: 10.1038/s41388-019-0699-4. Epub 2019 Jan 22.
5
Epigenetic mechanisms as a new approach in cancer treatment: An updated review.表观遗传机制作为癌症治疗的新方法：最新综述。
Genes Dis. 2018 Jun 18;5(4):304-311. doi: 10.1016/j.gendis.2018.06.003. eCollection 2018 Dec.
6
The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells.长链非编码 RNA MYCNOS-01 调节 MYCN 蛋白水平，并影响 MYCN 扩增型横纹肌肉瘤和神经母细胞瘤细胞的生长。
BMC Cancer. 2018 Feb 21;18(1):217. doi: 10.1186/s12885-018-4129-8.
7
DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation.体外敲低DNMT3B能够通过抑制增殖和诱导肌源性分化来逆转胚胎性横纹肌肉瘤细胞表型。
Oncotarget. 2016 Nov 29;7(48):79342-79356. doi: 10.18632/oncotarget.12688.
8
Classification of rhabdomyosarcoma and its molecular basis.横纹肌肉瘤的分类及其分子基础。
Adv Anat Pathol. 2013 Nov;20(6):387-97. doi: 10.1097/PAP.0b013e3182a92d0d.
9
Head and neck sarcomas: epidemiology, pathology, and management.头颈部肉瘤：流行病学、病理学和治疗。
Neurosurg Clin N Am. 2013 Jan;24(1):67-78. doi: 10.1016/j.nec.2012.08.010.
10
Rho GEFs and cancer: linking gene expression and metastatic dissemination.Rho GEFs 与癌症：连接基因表达和转移扩散。
Sci Signal. 2012 Oct 2;5(244):pe43. doi: 10.1126/scisignal.2003543.
Zotero 插件